Ocular Therapeutix (OCUL) announced that Namrata Saroj, OD, has joined the Company on a full-time basis as Chief Business Officer, CBO. Dr. Saroj previously served as Development Strategy Consultant to Ocular since February 2024.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OCUL:
- OCUL Upcoming Earnings Report: What to Expect?
- Disney initiated, Cisco upgraded: Wall Street’s top analyst calls
- Ocular Therapeutix initiated with an Outperform at Scotiabank
- Ocular Therapeutix management to meet with Piper Sandler
- Ocular announces accelerated timelines for SOL-1 registrational trial